An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

NCT03029988 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of effect in Cohort 1

Conditions

Liver Metastases
Colorectal Carcinoma

Interventions

DRUG: Tilmanocept (Technetium Tc 99m tilmanocept Injection)
PROCEDURE: SPECT/CT Imaging

Sponsor

Navidea Biopharmaceuticals

Collaborators

[object Object]
[object Object]